Oral versions of drugs like Wegovy and Mounjaro are expected to win TGA approval soon, following the US and Europe, AFR reports.
Recap by typeshit. Full story at AFR.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
POSAA wants the drugs on the PBS for the condition once called PCOS, where they're used off-label. Wegovy's revised listing bid goes back to the committee next month.
In a survey of 1,904 people, 39% of users reported nail detachment, against 9% of non-users. The authors say the design can't show the drugs caused it.
Loading…